Intermediate phenotypes in psychiatric disorders

Current Opinion in Genetics and Development

Volumn 21, Issue 3, 2011, Pages 340-348

  Rasetti, Roberta ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION; BRAIN FUNCTION; COGNITION; EFFECT SIZE; EMOTION; EPISODIC MEMORY; FACE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; HUMAN; MENTAL DISEASE; MOLECULAR GENETICS; NERVE CELL NETWORK; NEUROIMAGING; NEUROMODULATION; PARIETAL CORTEX; PATHOPHYSIOLOGY; PATTERN RECOGNITION; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SPEECH ARTICULATION; WORKING MEMORY;

BRAIN; BRAIN MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MEMORY, SHORT-TERM; MENTAL DISORDERS; PHENOTYPE; SCHIZOPHRENIA;

EID: 79957625912     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2011.02.003     Document Type: Review

References (72)

1. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
2. Cohen J.C., Boerwinkle E., Mosley T.H., Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006, 354:1264-1272.
3. Ji W., Foo J.N., O'Roak B.J., Zhao H., Larson M.G., Simon D.B., Newton-Cheh C., State M.W., Levy D., Lifton R.P. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008, 40:592-599.
4. Walters R.G., Jacquemont S., Valsesia A., de Smith A.J., Martinet D., Andersson J., Falchi M., Chen F., Andrieux J., Lobbens S., et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010, 463:671-675.
5. Hariri A.R., Weinberger D.R. Imaging genomics. Br Med Bull 2003, 65:259-270.
6. Bigos K.L., Weinberger D.R. Imaging genetics-days of future past. Neuroimage 2010, 53:804-809.
7. Drabant E.M., Hariri A.R., Meyer-Lindenberg A., Munoz K.E., Mattay V.S., Kolachana B.S., Egan M.F., Weinberger D.R. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry 2006, 63:1396-1406.
8. Egan M.F., Straub R.E., Goldberg T.E., Yakub I., Callicott J.H., Hariri A.R., Mattay V.S., Bertolino A., Hyde T.M., Shannon-Weickert C., et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 2004, 101:12604-12609.
9. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A 2005, 102:8627-8632.
10. Esslinger C., Walter H., Kirsch P., Erk S., Schnell K., Arnold C., Haddad L., Mier D., Opitz von Boberfeld C., Raab K., et al. Neural mechanisms of a genome-wide supported psychosis variant. Science 2009, 324:605.
11. Bigos K.L., Mattay V.S., Callicott J.H., Straub R.E., Vakkalanka R., Kolachana B., Hyde T.M., Lipska B.K., Kleinman J.E., Weinberger D.R. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry 2010, 67:939-945.
12. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645.
13. Egan M.F., Cannon T. Intermediate phenotypes and genetic origins. Schizophrenia 2011, Wiley-Blackwell, Oxford, UK. 3rd edn. D.R. Weinberger, P. Harrison (Eds.).
14. MacDonald A.W., Thermenos H.W., Barch D.M., Seidman L.J. Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives. Schizophr Bull 2009, 35:1142-1162.
15. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006, 7:818-827.
16. Goghari V.M. Executive functioning-related brain abnormalities associated with the genetic liability for schizophrenia: an activation likelihood estimation meta-analysis. Psychol Med. 2010, 14:1-14. [Epub ahead of print].
17. Whitfield-Gabrieli S., Thermenos H.W., Milanovic S., Tsuang M.T., Faraone S.V., McCarley R.W., Shenton M.E., Green A.I., Nieto-Castanon A., LaViolette P., et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A 2009, 106:1279-1284.
18. Rasetti R., Mattay V.S., Wiedholz L.M., Kolachana B.S., Hariri A.R., Callicott J.H., Meyer-Lindenberg A., Weinberger D.R. Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. Am J Psychiatry 2009, 166:216-225.
19. Karch S., Leicht G., Giegling I., Lutz J., Kunz J., Buselmeier M., Hey P., Sporl A., Jager L., Meindl T., et al. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task. J Psychiatr Res 2009, 43:1185-1194.
20. Callicott J.H., Egan M.F., Mattay V.S., Bertolino A., Bone A.D., Verchinksi B., Weinberger D.R. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 2003, 160:709-719.
21. Nicodemus KK, Callicott JH, Higier RG, Luna A, Nixon DC, Lipska BK, Vakkalanka R, Giegling I, Rujescu D, Clair DS. et al.: Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging. Hum Genet. 2010 Jan 19. [Epub ahead of print].
22. Straub R.E., Lipska B.K., Egan M.F., Goldberg T.E., Callicott J.H., Mayhew M.B., Vakkalanka R.K., Kolachana B.S., Kleinman J.E., Weinberger D.R. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry 2007, 12:854-869.
23. Krug A., Markov V., Eggermann T., Krach S., Zerres K., Stocker T., Shah N.J., Schneider F., Nothen M.M., Treutlein J., et al. Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with differences in frontal brain activation in a working memory task in healthy individuals. Neuroimage 2008, 42:1569-1576.
24. Buckholtz J.W., Meyer-Lindenberg A., Honea R.A., Straub R.E., Pezawas L., Egan M.F., Vakkalanka R., Kolachana B., Verchinski B.A., Sust S., et al. Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. J Neurosci 2007, 27:1584-1593.
25. Kircher T., Thienel R., Wagner M., Reske M., Habel U., Kellermann T., Frommann I., Schwab S., Wolwer W., von Wilmsdorf M., et al. Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci 2009, 259:72-79.
26. Kempf L., Nicodemus K.K., Kolachana B., Vakkalanka R., Verchinski B.A., Egan M.F., Straub R.E., Mattay V.A., Callicott J.H., Weinberger D.R., Meyer-Lindenberg A. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. PLoS Genet 2008, 4:e1000252.
27. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98:6917-6922.
28. Goldberg T.E., Straub R.E., Callicott J.H., Hariri A., Mattay V.S., Bigelow L., Coppola R., Egan M.F., Weinberger D.R. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 2006, 31:2022-2032.
29. Bertolino A., Fazio L., Caforio G., Blasi G., Rampino A., Romano R., Di Giorgio A., Taurisano P., Papp A., Pinsonneault J., et al. Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain 2009, 132(Pt 2):417-425.
30. Huffaker S.J., Chen J., Nicodemus K.K., Sambataro F., Yang F., Mattay V., Lipska B.K., Hyde T.M., Song J., Rujescu D., et al. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med 2009, 15:509-518.
31. Tan H.Y., Chen Q., Sust S., Buckholtz J.W., Meyers J.D., Egan M.F., Mattay V.S., Meyer-Lindenberg A., Weinberger D.R., Callicott J.H. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc Natl Acad Sci U S A 2007, 104:12536-12541.
32. Roffman J.L., Weiss A.P., Deckersbach T., Freudenreich O., Henderson D.C., Wong D.H., Halsted C.H., Goff D.C. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:990-995.
33. Nicodemus K.K., Law A.J., Radulescu E., Luna A., Kolachana B., Vakkalanka R., Rujescu D., Giegling I., Straub R.E., McGee K., et al. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch Gen Psychiatry 2010, 67:991-1001.
34. Jansen A., Krach S., Krug A., Markov V., Eggermann T., Zerres K., Stocker T., Shah N.J., Nothen M.M., Treutlein J., et al. A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe. Neuroimage 2009, 45:1002-1008.
35. Carter C.S., van Veen V. Anterior cingulate cortex and conflict detection: an update of theory and data. Cogn Affect Behav Neurosci 2007, 7:367-379.
36. Eisenberg D.P., Berman K.F. Executive function, neural circuitry, and genetic mechanisms in schizophrenia. Neuropsychopharmacology 2010, 35:258-277.
37. Sepede G., Ferretti A., Perrucci M.G., Gambi F., Di Donato F., Nuccetelli F., Del Gratta C., Tartaro A., Salerno R.M., Ferro F.M., Romani G.L. Altered brain response without behavioral attention deficits in healthy siblings of schizophrenic patients: an event-related fMRI study. Neuroimage 2010, 49:1080-1090.
38. McAllindon D.P., Wilman A.H., Purdon S.E., Tibbo P.G. Functional magnetic resonance imaging of choice reaction time in chronic schizophrenia and first-degree relatives. Schizophr Res 2010, 120:232-233.
39. Woodward N.D., Waldie B., Rogers B., Tibbo P., Seres P., Purdon S.E. Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with schizophrenia. Schizophr Res 2009, 109:182-190.
40. Blasi G., Mattay V.S., Bertolino A., Elvevag B., Callicott J.H., Das S., Kolachana B.S., Egan M.F., Goldberg T.E., Weinberger D.R. Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci 2005, 25:5038-5045.
41. Fan J., Fossella J., Sommer T., Wu Y., Posner M.I. Mapping the genetic variation of executive attention onto brain activity. Proc Natl Acad Sci U S A 2003, 100:7406-7411.
42. Thimm M., Krug A., Kellermann T., Markov V., Krach S., Jansen A., Zerres K., Eggermann T., Stocker T., Shah N.J., et al. The effects of a DTNBP1 gene variant on attention networks: an fMRI study. Behav Brain Funct 2010, 6:54.
43. Dickerson B.C., Eichenbaum H. The episodic memory system: neurocircuitry and disorders. Neuropsychopharmacology 2010, 35:86-104.
44. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999, 45:395-402.
45. Thermenos H.W., Seidman L.J., Poldrack R.A., Peace N.K., Koch J.K., Faraone S.V., Tsuang M.T. Elaborative verbal encoding and altered anterior parahippocampal activation in adolescents and young adults at genetic risk for schizophrenia using FMRI. Biol Psychiatry 2007, 61:564-574.
46. Thimm M., Krug A., Markov V., Krach S., Jansen A., Zerres K., Eggermann T., Stöcker T., Shah N.J., Nöthen M.M., et al. The impact of dystrobrevin-binding protein 1 (DTNBP1) on neural correlates of episodic memory encoding and retrieval. Hum Brain Mapp 2010, 31:203-209.
47. Krug A., Markov V., Krach S., Jansen A., Zerres K., Eggermann T., Stocker T., Shah N.J., Nothen M.M., Treutlein J., et al. The effect of Neuregulin 1 on neural correlates of episodic memory encoding and retrieval. Neuroimage 2010, 53:985-991.
48. Jansen A., Krach S., Krug A., Markov V., Thimm M., Paulus F.M., Zerres K., Stocker T., Shah N.J., Nothen M.M., et al. The effect of G72 genotype on neural correlates of memory encoding and retrieval. Neuroimage 2010, 53:1001-1006.
49. Di Giorgio A., Blasi G., Sambataro F., Rampino A., Papazacharias A., Gambi F., Romano R., Caforio G., Rizzo M., Latorre V., et al. Association of the SerCys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding. Eur J Neurosci 2008, 28:2129-2136.
50. Krach S., Jansen A., Krug A., Markov V., Thimm M., Sheldrick A.J., Eggermann T., Zerres K., Stocker T., Shah N.J., et al. COMT genotype and its role on hippocampal-prefrontal regions in declarative memory. Neuroimage 2010, 53:978-984.
51. Li X., Branch C.A., DeLisi L.E. Language pathway abnormalities in schizophrenia: a review of fMRI and other imaging studies. Curr Opin Psychiatry 2009, 22:131-139.
52. Sommer I.E., Ramsey N.F., Mandl R.C., van Oel C.J., Kahn R.S. Language activation in monozygotic twins discordant for schizophrenia. Br J Psychiatry 2004, 184:128-135.
53. Costafreda S.G., Fu C.H., Picchioni M., Kane F., McDonald C., Prata D.P., Kalidindi S., Walshe M., Curtis V., Bramon E., et al. Increased inferior frontal activation during word generation: a marker of genetic risk for schizophrenia but not bipolar disorder?. Hum Brain Mapp 2009, 30:3287-3298.
54. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Toulopoulou T., Bramon E., Walshe M., Murray R.M., Collier D.A., McGuire P. Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc Natl Acad Sci U S A 2009, 106:13600-13605.
55. Mechelli A., Prata D.P., Fu C.H., Picchioni M., Kane F., Kalidindi S., McDonald C., Demjaha A., Kravariti E., Toulopoulou T., et al. The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder. Neuroimage 2008, 42:817-826.
56. Markov V., Krug A., Krach S., Whitney C., Eggermann T., Zerres K., Stocker T., Shah N.J., Nothen M.M., Treutlein J., et al. Genetic variation in schizophrenia-risk-gene dysbindin 1 modulates brain activation in anterior cingulate cortex and right temporal gyrus during language production in healthy individuals. Neuroimage 2009, 47:2016-2022.
57. Krug A., Nieratschker V., Markov V., Krach S., Jansen A., Zerres K., Eggermann T., Stocker T., Shah N.J., Treutlein J., et al. Effect of CACNA1C rs1006737 on neural correlates of verbal fluency in healthy individuals. Neuroimage 2010, 49:1831-1836.
58. Kircher T., Krug A., Markov V., Whitney C., Krach S., Zerres K., Eggermann T., Stocker T., Shah N.J., Treutlein J., et al. Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals. Hum Brain Mapp 2009, 30:3406-3416.
59. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Kane F., Kalidindi S., McDonald C., Howes O., Kravariti E., Demjaha A., et al. Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol Psychiatry 2009, 65:473-480.
60. Prata D.P., Mechelli A., Picchioni M.M., Fu C.H., Toulopoulou T., Bramon E., Walshe M., Murray R.M., Collier D.A., McGuire P. Altered effect of dopamine transporter 3'UTR VNTR genotype on prefrontal and striatal function in schizophrenia. Arch Gen Psychiatry 2009, 66:1162-1172.
61. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Kane F., Kalidindi S., McDonald C., Kravariti E., Toulopoulou T., Miorelli A., et al. Effect of disrupted-in-schizophrenia-1 on pre-frontal cortical function. Mol Psychiatry 2008, 13:915-917. 909.
62. Krug A., Markov V., Krach S., Jansen A., Zerres K., Eggermann T., Stocker T., Shah N.J., Nothen M.M., Georgi A., et al. Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals. Hum Brain Mapp. 2011, 32(1):118-126.
63. Whalley H.C., Simonotto E., Flett S., Marshall I., Ebmeier K.P., Owens D.G., Goddard N.H., Johnstone E.C., Lawrie S.M. fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. Brain 2004, 127(Pt 3):478-490.
64. Whalley H.C., Simonotto E., Marshall I., Owens D.G., Goddard N.H., Johnstone E.C., Lawrie S.M. Functional disconnectivity in subjects at high genetic risk of schizophrenia. Brain 2005, 128(Pt 9):2097-2108.
65. Hall J., Whalley H.C., Moorhead T.W., Baig B.J., McIntosh A.M., Job D.E., Owens D.G., Lawrie S.M., Johnstone E.C. Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia. Biol Psychiatry 2008, 64:428-433.
66. Hall J., Whalley H.C., Job D.E., Baig B.J., McIntosh A.M., Evans K.L., Thomson P.A., Porteous D.J., Cunningham-Owens D.G., Johnstone E.C., et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 2006, 9:1477-1478.
67. McIntosh A.M., Baig B.J., Hall J., Job D., Whalley H.C., Lymer G.K., Moorhead T.W., Owens D.G., Miller P., Porteous D., et al. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol Psychiatry 2007, 61:1127-1134.
68. Marwick K., Hall J. Social cognition in schizophrenia: a review of face processing. Br Med Bull 2008, 88:43-58.
69. Barbour T., Murphy E., Pruitt P., Eickhoff S.B., Keshavan M.S., Rajan U., Zajac-Benitez C., Diwadkar V.A. Reduced intra-amygdala activity to positively valenced faces in adolescent schizophrenia offspring. Schizophr Res 2010, 123:126-136.
70. Habel U., Klein M., Shah N.J., Toni I., Zilles K., Falkai P., Schneider F. Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients. Am J Psychiatry 2004, 161:1806-1813.
71. Munafo M.R., Brown S.M., Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry 2008, 63:852-857.
72. Smolka M.N., Schumann G., Wrase J., Grusser S.M., Flor H., Mann K., Braus D.F., Goldman D., Buchel C., Heinz A. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 2005, 25:836-842.